Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
J Parasitol ; 101(4): 488-9, 2015 Aug.
Article de Anglais | MEDLINE | ID: mdl-25764145

RÉSUMÉ

Here we report the case of a 42-yr-old patient who presented himself to us with a serpiginous erythematous lesion from the wrist of the right forearm up the arm to the right shoulder A similar lesion of a smaller size was also present in the left forearm. On the basis of clinical manifestations and progression of the lesion, combined with previous treatments and different diagnostic investigations, hookworm-related cutaneous larva migrans (HrCLM) disease was hypothesized. Albendazole was employed as treatment and the resolution of the symptoms confirmed the diagnosis. The relevance of the reported case relies on 3 main aspects: the acquisition of the disease in Italy, the initial treatment with topical corticosteroids that sped up the progression of the cutaneous trail, and the uncommon location of the lesions. Furthermore, the anamnestic data and the laboratory/clinical investigations strongly suggested an occupational exposure to the etiological agent. As illustrated here, HrCLM might represent a challenge for Western physicians in terms of diagnosis, treatment, and ways of acquisition. Describing the clinical presentation and the treatment of cases of cutaneous larva migrans might contribute to early and correct diagnosis, to an increase of our knowledge on this disease, and to an update on its epidemiology.


Sujet(s)
Infections à ankylostomes/complications , Larva migrans/diagnostic , Maladies professionnelles/diagnostic , Hormones corticosurrénaliennes/administration et posologie , Hormones corticosurrénaliennes/effets indésirables , Adulte , Albendazole/usage thérapeutique , Animaux , Antihelminthiques anticestodes/usage thérapeutique , Bras , Diagnostic différentiel , Avant-bras , Humains , Italie , Larva migrans/traitement médicamenteux , Larva migrans/parasitologie , Mâle , Maladies professionnelles/traitement médicamenteux , Maladies professionnelles/parasitologie , Exposition professionnelle , Manipulation d'échantillons/effets indésirables , Pouce , Zoologie
2.
Infection ; 39(2): 127-33, 2011 Apr.
Article de Anglais | MEDLINE | ID: mdl-21327628

RÉSUMÉ

BACKGROUND: Outbreaks of vancomycin-resistant Enterococcus faecium (VRE) strains is an emerging problem worldwide. Even if still relatively uncommon in European hospitals, infections caused by VRE have also been increasing recently in this continent. METHODS: In this study, we characterized 50 consecutive VRE and 23 vancomycin-sensitive E. faecium (VSE) isolates collected in an Italian hospital. The presence of the esp gene and that of genes encoding resistance to glycopeptides was investigated by polymerase chain reaction (PCR). All of the isolates were typed by multi-locus sequence typing (MLST), and a selection of them also by pulsed-field gel electrophoresis (PFGE). RESULTS: We found that all of the VRE and 18 (78%) of the VSE strains belonged to the single clonal complex-17 (CC17). The most represented sequence type (ST) was ST78 (34% of the isolates). When further analyzed by PFGE, ST78 isolates were subdivided into five pulsotypes, four of them closely related. The strong association between the esp gene and CC17 was confirmed. Interestingly, such an association was higher among vancomycin-resistant isolates. Most of the esp-positive isolates (34/46, 74%) encoded Esp4, a rare variant of this protein characterized by the absence of A repeats. CONCLUSIONS: Our findings underscore the role of the CC17 lineage in the nosocomial spread of VRE and VSE, and its rapid local evolution, underscoring the need for programs designed to provide early detection in order to prevent its spreading among the nosocomial population.


Sujet(s)
Infection croisée/épidémiologie , Enterococcus faecium/classification , Enterococcus faecium/génétique , Infections bactériennes à Gram positif/épidémiologie , Antibactériens/pharmacologie , Techniques de typage bactérien , Analyse de regroupements , Infection croisée/microbiologie , Électrophorèse en champ pulsé , Enterococcus faecium/effets des médicaments et des substances chimiques , Enterococcus faecium/isolement et purification , Gènes bactériens , Génotype , Infections bactériennes à Gram positif/microbiologie , Hôpitaux , Humains , Italie , Tests de sensibilité microbienne , Épidémiologie moléculaire , Typage par séquençage multilocus , Vancomycine/pharmacologie
3.
Parassitologia ; 45(1): 19-22, 2003 Mar.
Article de Italien | MEDLINE | ID: mdl-15270539

RÉSUMÉ

Dientamoeba fragilis is a pathogenic protozoan parasite with a world-wide distribution. Interestingly, a resistant cyst stage has not been demonstrated and it is still an unsolved problem how this parasite can survive successfully outside the human host. D. fragilis was found in 2% of approximately 2500 individuals unselected who submitted stools for parasitological examination during 2001 in Padua (Italy). The goal of this study was to detect the protozoan stages and the duration of persistence of this protozoa in faeces stored in different environmental conditions. The trophozoites of D. fragilis were detected up to 60 days after the collection of the faeces stored at 4 degrees C and Giemsa stained. The laboratory detection rate of the organism is greatly enhanced by use of preservative to fix stool specimens immediately after passage. Alternatively, a microscopic observation of the collected stool has to be performed immediately after passage followed by examination of permanently-stained smears. Demonstration of the charateristic "golf-club" and "acanthopodia-like" structures in unstained fixed faecal material by direct microscopy (400x) are suitable for a rapid identification of D. fragilis.


Sujet(s)
Dientamoeba/isolement et purification , Infection à Dientamoeba/diagnostic , Fèces/parasitologie , Manipulation d'échantillons/méthodes , Animaux , Colorants azurés/pharmacologie , Dientamoeba/effets des médicaments et des substances chimiques , Dientamoeba/croissance et développement , Dientamoeba/ultrastructure , Infection à Dientamoeba/parasitologie , Fixateurs/pharmacologie , Humains , Coloration et marquage/méthodes , Facteurs temps
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE